Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Neurology
•
Neuro-immunology
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
Related Questions
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
What is your treatment approach to neuropsychiatric symptoms secondary to lupus?
How do you approach new onset idiopathic intracranial hypertension (IIH) with someone who has history of systemic lupus erythematosus? Would you consider this to be neuropsychiatric SLE (NPSLE) manifesting as IIH?
Do you obtain an MSLT or start empiric therapy with modafinil in patients with residual excessive daytime sleepiness despite optimal adherence to PAP therapy?
Do you use amyloid lowering therapy in patients on chronic anticoagulation?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
How do you manage stroke-related abulia?
Would you recommend dual antiplatelet therapy or anticoagulation for a patient previously on aspirin who has a breakthrough stroke with history of CADASIL?
